A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease (NCT06807463)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2a Trial to Characterize the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease While Undergoing Oral Gluten Exposure
🩺 Plain-English Summary (8th-Grade Level)
The primary efficacy objective of the trial is to assess the ability of TEV-53408 to attenuate gluten-induced enteropathy in adults with celiac disease. The primary safety objective of the trial is to assess the safety of TEV-53408 in adults with celiac disease. A secondary objective is to further assess the efficacy of TEV-53408 in adults with celiac disease. The expected trial duration per participant is approximately 86 weeks.
Who can join: Review the eligibility criteria below.
Location: Teva Investigational Site 12138 — Murrieta, California
Age range: 18 Years to 64 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (21 Sites)
- Teva Investigational Site 12138 — Murrieta, California
- Teva Investigational Site 12131 — Colorado Springs, Colorado
- Teva Investigational Site 12134 — Inverness, Florida
- Teva Investigational Site 12126 — Miami Lakes, Florida
- Teva Investigational Site 12135 — New Port Richey, Florida
- Teva Investigational Site 12130 — Atlanta, Georgia
- Teva Investigational Site 12133 — Marrero, Louisiana
- Teva Investigational Site 12132 — Clinton Township, Michigan
- Teva Investigational Site 12121 — Wyoming, Michigan
- Teva Investigational Site 12129 — Rochester, Minnesota
- Teva Investigational Site 12128 — New York, New York
- Teva Investigational Site 12125 — Greenville, North Carolina
- Teva Investigational Site 12127 — Winston-Salem, North Carolina
- Teva Investigational Site 12137 — Waco, Texas
- Teva Investigational Site 12122 — Ogden, Utah
- Teva Investigational Site 12123 — Lynchburg, Virginia
- Teva Investigational Site 78139 — Fitzroy,
- Teva Investigational Site 78140 — Maroochydore,
- Teva Investigational Site 78137 — Midland,
- Teva Investigational Site 40063 — Helsinki,
- Teva Investigational Site 40062 — Tampere,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Celiac Disease
- A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease — Stanford, California
- Immune Responses to Gluten — Aurora, Colorado
- Tissue Destruction and Healing in Celiac Disease — Pasadena, California
- Gluten Technology and Education for Celiac Health — Chicago, Illinois
- Study of DONQ52 in Active Celiac Disease — Anniston, Alabama
Explore by condition: All Celiac Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.